Taking advantage of the fact that STAT3 is overexpressed or hyperactivated in ovarian cancer cells, inhibiting STAT3 activation can dramatically suppress tumor growth, suggesting that STAT3 signaling is a promising target for ovarian cancer therapy [11,12,13]. The gene discussed is STAT3; the disease is ovarian carcinoma.